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The spleen is an important site for central regulation of immune function by noradrenergic sympathetic nerves, but little is known about this major region of neuroimmune
communication in humans. Experimental studies using animal models have established
that sympathetic innervation of the spleen is essential for cholinergic anti-inflammatory
responses evoked by vagal nerve stimulation, and clinical studies are evaluating this
approach for treating inflammatory diseases. Most data on sympathetic nerves in
spleen derive from rodent studies, and this work has established that remodeling of
sympathetic innervation can occur during inflammation. However, little is known about
the effects of sepsis on spleen innervation. Our primary goals were to (i) localize noradrenergic nerves in human spleen by immunohistochemistry for tyrosine hydroxylase
(TH), a specific noradrenergic marker, (ii) determine if nerves occur in close apposition
to leukocytes, and (iii) determine if splenic sympathetic innervation is altered in patients
who died from end stage sepsis. Staining for vesicular acetylcholine transporter (VAChT)
was done to screen for cholinergic nerves. Archived paraffin tissue blocks were used.
Control samples were obtained from trauma patients or patients who died after hemorrhagic stroke. TH + nerves were associated with arteries and arterioles in all control
spleens, occurring in bundles or as nerve fibers. Individual TH + nerve fibers entered
the perivascular region where some appeared in close apposition to leukocytes. In
marked contrast, spleens from half of the septic patients lacked TH + nerves fibers
and the average abundance of TH + nerves for the septic group was only 16% of that
for the control group (control: 0.272 ± 0.060% area, n = 6; sepsis: 0.043 ± 0.026%
area, n = 8; P < 0.005). All spleens lacked cholinergic innervation. Our results provide definitive evidence for the distribution of noradrenergic nerves in normal human
spleen and the first evidence for direct sympathetic innervation of leukocytes in human
spleen. We also provide the first evidence for marked loss of noradrenergic nerves in
patients who died from sepsis. Such nerve loss could impair neuroimmunomodulation
and may not be limited to the spleen.
Keywords: noradrenergic, cholinergic, human, spleen, sepsis, innervation, remodeling
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INTRODUCTION

in knowledge, we used immunohistochemistry to evaluate the
presence and localization of noradrenergic sympathetic nerves
in sections of control spleens and spleens from patients with end
stage sepsis. Additional immunostaining was done for the vesicular acetylcholine transporter (VAChT) to evaluate the presence of
cholinergic nerves in the spleen.

The central nervous system (CNS) and immune system play
essential roles in maintaining homeostasis, and there is extensive
evidence for crosstalk between these systems (1–5). Mediators
generated during injury or inflammation stimulate sensory
pathways to the brain, which responds by activating the hypothalamic–pituitary–adrenal axis and efferent autonomic neural
pathways. Activation of the sympathetic nervous system (SNS)
evokes well-known cardiovascular and metabolic responses
aimed at addressing threats to homeostasis. As the sole source
of efferent neural input to primary and secondary lymphoid tissues, the SNS also plays an essential role in CNS modulation of
immune function (1, 6, 7). These effects on immune function can
be indirect through modulation of blood flow or direct through
stimulation of adrenergic receptors on leukocytes (1).
The spleen is the largest secondary lymphoid tissue and a
major hub of innate and adaptive immune responses, making it
a prime target for regulation by the SNS (1, 3, 8). Experimental
studies have shown that the spleen is a major contributor to
the exaggerated inflammatory response that occurs in sepsis,
trauma, and burn injuries (3). Furthermore, adverse cellular
and functional remodeling of the spleen contributes to immunosuppression in patients who die from sepsis and multiple
organ failure (9). Accordingly, understanding neuromodulatory mechanisms that operate within the spleen has significant
translational value. Neuroanatomical studies, done primarily
with small animal models, have shown that sympathetic nerves
enter the spleen with major vessels and distribute throughout
the arterial vasculature (1, 10). Many sympathetic nerve fibers
travel into the periarterial lymphatic sheath (PALS) where some
occur in close apposition to T cells, B cells, and macrophages,
providing a structural basis for direct neuromodulation of
immune function (10–13). Diffusion of catecholamines from
their release sites would also affect more leukocytes via so-called
volume transmission (1, 2, 5, 12).
Both the spleen and its sympathetic nerves have essential
roles in the cholinergic anti-inflammatory pathway (3, 4, 8).
Activation of splenic sympathetic nerves by reflex mechanisms
or vagal nerve stimulation triggers release of norepinephrine
(NE), which stimulates β2-adrenergic receptors on cholinergic
T cells, causing release of acetylcholine (ACh). Then, ACh elicits
an anti-inflammatory response mediated by α7 nicotinic ACh
receptors on macrophages (3, 8). In addition to this mechanism,
there is substantial evidence that catecholamines can affect the
functions of macrophages, dendritic cells, Tregs, and B cells by
stimulation of surface adrenergic receptors (1).
The translational potential for neural modulation of immune
function in disease is already being tested in ongoing clinical
trials of vagal nerve stimulation, which activates sympathetic
input to the spleen (3). However, most studies that defined the
localization of sympathetic nerves in spleen used animal models,
and our knowledge regarding sympathetic innervation of adult
human spleen is very sparse (14). Furthermore, experimental
studies provide evidence that sympathetic innervation of the
spleen can change with age and inflammatory disease (5, 15–17),
but analogous human data are lacking. To address these gaps
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MATERIALS AND METHODS
Human Tissue Samples

All tissue sections evaluated in this study were obtained from
paraffin-embedded samples graciously provided by Dr. Richard
Hotchkiss at Washington University. Many of these samples
were used in prior studies of sepsis by Hotchkiss and his colleagues (9). All of these studies were approved by the Washington
University or St. John’s Hospital Human Research Protection
Office, with informed consent, which included permission to
collect tissue for research purposes, provided by a next-of-kin in
accordance with the Declaration of Helsinki. Spleen samples from
septic patients who died in the intensive care unit were obtained
by immediate, limited autopsy performed at bedside after obtaining permission from next-of-kin. Control samples were obtained
during surgical removal of the spleen to control bleeding after
upper body trauma, from organ donors with permission from
next-of-kin to collect tissue for research purposes, and postmortem from patients with subarachnoid hemorrhage. Clinical information provided to us and comments on hematoxylin and eosin
(H&E) stained sections of spleens are summarized in Table 1.

Tissue Processing and
Immunohistochemistry

5 µm sections of paraffin-embedded spleens and a control sample
of intestine were cut using a Leica RM2135 microtome, collected
on charged slides, and stained with H&E or processed for bright
field immunohistochemistry using standard procedures (18, 19).
Briefly, sections were deparaffinized, rehydrated, and incubated
in citrate buffer (pH 6.5) for 20 min at 92°C for antigen retrieval.
Sections were washed with 0.1 M phosphate-buffered saline (PBS,
pH 7.3), permeabilized in PBS containing 0.4% Triton X-100 and
0.5% bovine serum albumin, and treated with 1% H2O2 in PBS for
15 min. After additional washing and blockade in PBS containing
5% normal goat serum, 1% BSA, and 0.4% Triton X-100, the sections were incubated with primary antibody overnight. Primary
antibodies were rabbit anti-tyrosine hydroxylase (TH) (1:1,000,
Pel-Freez Cat. # P40101; Rogers, AR, USA) or rabbit anti-VAChT
(1:1,000, Cat. # 139103; Synaptic Systems, Göttingen, Germany).
Further processing was done using a Rabbit ABC kit (Vector
Laboratories), and Vector ImmPact VIP chromogen (Vector
Laboratories) was used to produce a purple reaction product
at sites of antigen localization. For some sections from control
spleens, Vector ImmPact DAB was used as the chromogen to stain
TH nerves brown, and hematoxylin was used as a counterstain
to visualize nuclei. Slide-mounted sections were viewed using
an Olympus BX4 microscope, and digital images were obtained
using an attached Olympus Q-Color 3 digital camera and Q-Cap
Pro 7 software.
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Table 1 | Patient profiles.
Group

Gender

Age Clinical situation

Hematoxylin and eosin histology

Controls

Female
Female
Male
Male
Male
Male

74
51
NA
NA
NA
NA

Subarachnoid hemorrhage
CHF, COPD, subarachnoid hemorrhage
Trauma
Trauma
Trauma
Trauma

Some white pulp (WP) loss, no germinal centers (GC)
Some WP loss, rare GC
Normal
Normal
Normal
Normal, no GC

Septic

Male
Female

63
87

Marked WP loss, no GC, much hemosiderin
Poorly defined WP, no GC

Female

70

Female
Male
Male
Male
Female

87
80
62
60
NA

Pancreatitis, multiple intra-abdominal abscesses, VAP, renal failure
S/P pelvic exenteration for cervical cancer, bacteremia w/respiratory distress,
hypotension
S/P femoral popliteal bypass, anemia, massive MI, vasopressors, ischemic bowel on
postmortem
Ischemic colitis, septic about 2 days
Upper GI bleed and peritonitis
Septic w/dead gut
Septic w/peritonitis and obese
Influenza complicated by bacterial pneumonia

Analysis of TH Nerve Fiber Abundance

Decreased WP, rare GC
Marked WP loss, no GC
Marked WP loss, no GC
Some WP, empty sinusoids
Decreased WP

were obtained at postmortem examination. The spleens of the
traumatized controls showed well-defined white pulp (WP) with
numerous germinal centers (GC) and unremarkable vessels. The
spleens of the controls with terminal subarachnoid hemorrhage
showed well defined but less extensive WP with fewer GC. They
also showed hyalinizing vascular changes that are common agerelated changes at postmortem examination. The WP was greatly
decreased in seven out of eight septic spleens (in the fourth it
was very poorly delineated), and GC were very rare to completely
lacking in all specimens. One septic spleen showed abundant
hemosiderin deposition.
Sympathetic nerves were identified by immunostaining
spleen sections for TH, the rate-limiting enzyme for synthesis
of the noradrenergic neurotransmitter, NE. Such nerves were
prominent in all control patients, with no qualitative difference
between TH staining of spleens obtained at surgery compared
to those obtained at autopsy. TH + nerves entered the spleen
in large bundles associated with penetrating vessels (Figure 1A)
and continued to be present in bundles of decreasing size along
the arterial vasculature within the parenchyma of the spleen
(Figures 1C,D,F,H). The splenic artery, trabecular arteries,
central arteries, and smaller branches down to arterioles were
surrounded by individual nerves fibers present at the adventitiamedia border and in the adventitia (Figures 1A,C–F,H–J).
Subscapular TH + nerve fibers were abundant in sections from
one trauma patient, who had the most robust sympathetic
innervation (Figure 1G). However, none of the control patients
had sympathetic nerves within the capsule (Figure 1G). While
the vast majority of sympathetic nerves in the control spleens
were associated with the arterial vasculature, several TH + nerve
fibers extended short distances into the PALS (Figures 1F, 2
and 3). Sympathetic nerves were not present in follicles or GC
(Figures 2A,B). Examination of perivascular regions of control
human spleens at high resolution with a 100× oil objective
revealed extremely close apposition of nerve fibers and varicosities with leukocytes (Figures 2C-I and 3).
In sharp contradistinction to control spleens, TH + nerve
bundles and fibers were lacking in four of the eight septic spleens

We performed semi-quantitative and quantitative analyses to
evaluate the abundance of TH-stained nerves fibers in spleen
sections. Both analyses were performed in a blinded fashion.
Semi-quantitative evaluation of TH staining was performed by a
neuropathologist using the following grading scale: 0—no staining, 1—staining just around large vessels near the capsule, 2—
staining around large vessels and trace staining in parenchyma
including small vessels, and 3—staining around large vessels and
in parenchyma.
Quantitative evaluation of TH nerve fiber abundance was
performed using ImageJ software (U.S. National Institutes of
Health, Bethesda, MD, USA). Slides were viewed with a 20× objective and scanned in a standard pattern, collecting non-overlapping
images of fields containing at least one blood vessel. This process
resulted in 15–45 images per section, depending on the area of
the section. These images were analyzed in a blinded fashion by
another individual to determine the % of each field that contained
TH + nerve fibers. Resulting data are presented as % area.

Statistical Analyses

Statistical analysis of nerve abundance data was performed
using GraphPad Prism version 6.00 (GraphPad Software, La Jolla,
CA, USA). Semi-quantitative data for control and sepsis groups
were compared by non-parametric analysis using a two-tailed
Mann–Whitney test for unpaired observations. Quantitative data
were compared by using a two-tailed t-test for unpaired samples.
A P value less than 0.05 was considered significant. Data are
presented as mean ± SD.

RESULTS
Clinical and general histological details of patients from whom
spleens were obtained retrospectively for examination are
presented in Table 1. There were six control specimens: these
were obtained from four trauma patients and two who died
after subarachnoid hemorrhage whose spleens were obtained
at autopsy. The spleens of eight patients who died with sepsis

Frontiers in Immunology | www.frontiersin.org
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Figure 1 | Control human spleens had abundant tyrosine hydroxylase (TH) + sympathetic nerves associated with the vasculature and lacked cholinergic
innervation. (A,B) Images showing noradrenergic (TH+) nerve fibers and bundles around splenic artery and branches (A) and absence of cholinergic (VAChT) nerves
in an adjacent section (B) from a 74-year-old female. (C) Low magnification image of TH + nerve fibers and bundles around a trabecular artery in a spleen section
from a male trauma patient. Arrows indicate TH + nerve fibers around an adjacent large vein. (D,E) TH + fibers associated with central artery and smaller branches
in the same 74-year-old female. Nerve fibers are localized to adventitia and adventitia-media border. Arrow in (D) indicates nerve around branch of central artery
shown at higher magnification in (E). (F) Sympathetic nerves around a central artery and branch from another trauma patient. Arrows indicate some TH + nerve
fibers that entered the periarterial lymphatic sheath. (G) Same patient had TH + nerve fibers (some indicated by arrows) in lymphatic tissue under the capsule.
(H,I) TH + fibers around small, branching arteries in sections from first trauma patient (H) and from a 57-year-old female (I). (J) Periarteriolar TH + nerve fibers in
spleen section from a 74-year-old female. TH + nerve fibers extend a short distance into surrounding lymphatic tissue. Open arrows indicate some TH + nerve
bundles. Scale bars: 250 µm (A–C); 100 µm (D,F–I); 50 µm (E,J).

and greatly reduced in number in the other four (Figure 4).
Residual TH + nerves in the latter spleens were localized primarily to larger vessels, where they occurred in much smaller
bundles. Noradrenergic nerve fibers were uncommon in smaller
vessels and seldom extended into perivascular regions of the
septic spleens. Abnormal axonal profiles were identified among
the residual TH + nerve fibers in spleens from septic patients
(Figures 4G–I). Sympathetic nerve abundance in spleens from
control and septic patients was evaluated and compared semiquantitatively using an arbitrary grading scale and quantitatively
by measuring area occupied by TH + neural elements. Both
methods demonstrated significant decreases in TH + nerve
fiber abundance in spleens from septic patients compared to
controls (Figure 5). Quantitative evaluation of TH + nerve
staining showed that the average abundance of TH + nerves
in the septic group was only 16% of that for the control group
(control: 0.272 ± 0.060% area, n = 6; sepsis: 0.043 ± 0.026%
area, n = 8; P < 0.005).
We also evaluated adjacent sections of spleen for the presence
of VAChT, which is a specific marker for cholinergic nerves.
No VAChT + nerves fibers or bundles were detected in any of
the spleen sections (Figure 1B), but prominent cholinergic nerve

Frontiers in Immunology | www.frontiersin.org

fibers were detected in a section of human intestine processed in
the same experiment (Figure 6).

DISCUSSION
Sympathetic innervation of lymphoid tissues, such as the spleen,
has been recognized for a long time (14, 20, 21), but the precise
localization of noradrenergic nerve fibers within these tissues has
only been revealed with modern neuroanatomical techniques
over the past three decades. The vast majority of this work
was performed using animal models, and data obtained from
human lymphoid tissue are sparse (14). Our findings address
this gap in knowledge by providing a detailed localization of
noradrenergic nerve fibers in normal human spleen, and we also
present evidence for sympathetic remodeling in patients with
end stage sepsis. These findings are especially significant given
recent advances in our understanding of functional interactions
between sympathetic nerves and immune cells in the spleen.
We observed that noradrenergic nerves are abundant
throughout the arterial vasculature of control human spleens but
absent in the splenic capsule. These neuroanatomic findings are
consistent with functional data obtained from early experimental
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Figure 2 | Sympathetic nerves in perivascular lymphatic tissue of control spleens have close association with leukocytes. (A,B) Hematoxylin and eosin stain of
small arteries associated with a splenic nodule (n) in section from a trauma patient (A) and tyrosine hydroxylase (TH) + nerve fibers around same vessels in adjacent
section (B). Small boxes indicate regions shown at higher magnification (C,D) to demonstrate close apposition of sympathetic nerves with leukocytes. (E,F) Close
apposition of sympathetic nerves with perivascular leukocytes (arrows) in spleen sections from female patients who were 74 and 57 years old, respectively. (G–I)
Close apposition of TH + nerve processes with perivascular leukocytes (some indicated by arrows) in spleen section from another trauma patient. Scale bars:
100 µm (A,B); 25 µm (C–I).

studies of isolated perfused human spleens (20, 22). The latter
work showed that stimulation of postganglionic sympathetic
nerves to the human spleen or close arterial injection of NE or
epinephrine had only minor effects on spleen volume but caused
graded vasoconstriction. This contrasts with dogs, which showed
vasoconstriction and a large reduction of spleen volume due to
contraction of smooth muscle in the capsule (20, 23).
Our immunohistochemical findings provide the first, highresolution evidence for localization of sympathetic nerves
in the splenic vasculature of adult humans lacking major systemic pathology. This builds on previous work, which used a
fluorescence histochemical method, to visualize catecholaminecontaining nerves in spleens obtained from patients with gastrointestinal pathology, primarily advanced gastric cancer (14).
The latter study also reported the presence of cholinergic nerves
in the human spleen based on staining for acetylcholinesterase,
which is now known to be a non-specific marker that also labels
some non-cholinergic nerves. Our staining for the VAChT, a
selective cholinergic marker and protein required for cholinergic neurotransmission, did not detect cholinergic nerves in
the spleen but did show parasympathetic nerves in a control
sample from human intestines, which was processed with the
spleen sections. Thus, our findings for human spleen support the
conclusion, based on work with other species, that the spleen
lacks cholinergic parasympathetic innervation (1, 3, 6).

Frontiers in Immunology | www.frontiersin.org

While a vast majority of sympathetic nerves in the human
spleen were associated with the vasculature, we observed several
smooth and varicose TH + nerve fibers that entered periarterial
regions of control spleens where they occurred in close proximity to leukocytes. To the best of our knowledge, this is the first
demonstration of TH + nerves within leukocyte regions of the
human spleen. We did not examine the phenotype of leukocytes
that occurred in close apposition to TH + nerves in the human
spleen, but other investigators identified T cells, B cells, and macrophages associated with noradrenergic nerve fibers in rodent
spleens (10–13). It is important to note that most of these nerve
fibers traveled relatively short distance into the parenchyma of
the spleen. This pattern differs from results for rats, mice, and
rabbits, which have dense noradrenergic innervation throughout
the white pulp (24). Ultrastructural studies of rat spleen have
demonstrated that some leukocyte and axonal membranes are
separated by as little at 6 nm at points of close apposition (10).
However, the abundance of such “synapse-like” structures was
not reported, and this mode of transmission would be atypical for
the autonomic nervous system where varicosities are separated
from effector tissues by gaps ranging from about 20 nm to about
2 µm (25). Direct communication between noradrenergic nerve
fibers and cholinergic T cells in the spleen was suggested to play
a mechanistic role in the vagal anti-inflammatory pathway (13).
However, recent neuroanatomical studies found that less than
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Sympathetic effects on spleen function would undoubtedly
suffer during sepsis based on the deficiency of TH + nerves we
detected in pathological samples. We do not know why sympathetic nerves are lost in the spleen of patients with end stage
sepsis or if this change is restricted to the spleen. However, there
is abundant evidence for plasticity of noradrenergic sympathetic
nerves in human inflammatory diseases and animal models
(5, 16, 26–28). This work suggests that nerve loss could be due
to changes in the local environment that (1) decrease availability
of neurotrophic factors that support sympathetic neurites, (2)
increase the production of inflammatory cytokines and/or nerve
repellant chemicals, and/or (3) generate toxic free radicals.
Sympathetic neurons require stimulation by nerve growth
factor (NGF) for survival during development and for maintenance of sympathetic innervation throughout life (29). NGF is
a target-derived neurotrophic factor that is secreted by adrenoceptive cells in organs and tissues innervated by noradrenergic
nerves. Recent studies have shown that NGF is synthesized in
and released by several types of immune cells including T cells,
B cells, and macrophages (30–32). Since T and B cell abundance
in the spleen is reduced substantially during sepsis due to
apoptosis (9, 33, 34), it is reasonable to conclude that the supply
of NGF to support sympathetic innervation would likewise be
reduced (Figure 7). Previous studies identified significant loss
of noradrenergic nerves and reduction of NE content in spleen
and other lymphoid tissue of old F344 rats (16, 35), and several
mechanisms have been proposed as causative factors in this agedependent loss of sympathetic nerves (17, 36–38). Deficiency of
neurotrophic factors ranks among these since aging-associated
loss of noradrenergic nerves in the spleen and reduction of NE
content occur in parallel with signs of immunosuppression (17).
Aging alone is not universally associated with loss of sympathetic nerves since noradrenergic nerves are well maintained
in the spleen of several strains of mice and rats (15, 39), and we
observed prominent TH + nerves in spleen from a 74-year-old
control female patient. Rather, it is likely that overall health and
specifically health of the immune system are critical factors.
Damage from free radicals was proposed as another contributor to age-associated sympathetic nerve loss in the spleen
and lymphoid tissue of rats (38, 40, 41), and free radicals are
clearly generated during sepsis. Thus, reactive oxygen and
nitrogen species generated in the spleen might trigger nerve
loss by direct toxic effects on TH + nerves and by toxic effects
on target cells, resulting in reduced production of neurotrophic
factors (Figure 7). Several studies have shown that treatment
of old rats with l-deprenyl, an agent known to increase activity
of scavenger enzymes and reduce oxidative stress (42), causes
partial restoration of noradrenergic nerves in the spleen and
improves immune function (38, 40, 41). Part of this effect may
be due to reduction of free radicals but l-deprenyl might also
have neurotrophic actions (43).
Previous studies reported loss of sympathetic nerve fibers in
several tissues during inflammation, an effect most thoroughly
studied in synovial tissue from patients with rheumatoid arthritis
(RA) and in experimental models of RA (5). Upregulation of
nerve repellant factors such as semaphorin 3C and 3F in inflamed
joints has been implicated in the selective loss of TH + nerves

Figure 3 | Close association of tyrosine hydroxylase (TH) + nerves and
leukocytes demonstrated in dual stained sections. (A–F) High magnification
images of control spleen sections with TH + nerves stained brown using DAB
and nuclei stained blue with hematoxylin to enhance identification of
leukocytes. Arrows indicate some TH + nerves in close apposition to
leukocytes. Scale bars: 25 µm (A,C–F); 50 µm (B).

5% of cholinergic T cells occurred within 8 µm of a TH + axon
(12). These investigators proposed that communication between
noradrenergic nerves and cholinergic T cells in the spleen is
more likely to occur by “volume transmission,” where the sphere
of nerve influence is determined by diffusion of NE. Since most
of the noradrenergic nerves that we identified in human spleen
were localized in and close to blood vessels, diffusion of NE into
surrounds PALS could provide a major mechanism for neuroimmune regulation in humans.
Much of the knowledge that we have regarding effects of
adrenergic neurotransmitters on the immune system comes from
in vitro or ex vivo studies of immune cells and studies of immune
cell lines (1, 5). This work has shown that virtually all types of
immune cell express adrenergic receptors, with the specific
receptor types showing plasticity related to factors such as time,
activation state, and duration of exposure to agonist. Adrenergic
agonists can affect both innate and adaptive immune responses
with activation of β2-adrnergic receptors on immune cells often
mediating anti-inflammatory effects and α2 receptors mediating
pro-inflammatory effects. Knowledge about specific neuronal–
immune cell interactions in the spleen was sparse until the
recent discovery of the cholinergic anti-inflammatory pathway.
This work has established that noradrenergic nerves and cholinergic T cells in the spleen are crucial for the anti-inflammatory
response to vagal nerve stimulation in endotoxemia and several
other inflammatory states (3, 4, 8).

Frontiers in Immunology | www.frontiersin.org
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Figure 4 | Loss of sympathetic nerves in spleens from patients who died with sepsis. (A,B) Hematoxylin and eosin stain (A) and tyrosine hydroxylase (TH) stain (B)
of spleen section from 63-year-old male. Note absence of TH + nerve fibers around arteries. (C) Absence of TH + nerves around large artery (*) and smaller artery
(a) in spleen section from an 87-year-old female patient. Sections from both of these patients lacked sympathetic nerves. (D–F) Images showing reduced
abundance of periarterial TH + nerve fibers in spleen from a 70-year-old female patient who died with sepsis. Large (D) and intermediate (E) diameter arteries show
marked reduction of TH + nerve fibers compared to control patients and lacked large TH + nerve bundles. Smaller arteries (F) lacked TH + nerve fibers in this
patient. (G) Solitary axon retraction ball in white pulp. (H) Tortuous reactive axonal profile with highly variable axonal diameter. (I) Axonal swelling where apparently
intact axon profiles enter and leave zone of interrupted axonal transport. Scale bars: 100 µm (A,B,F); 250 µm (C–E); 25 µm (G–I).

and a plexin signaling unit (26, 44, 45). Immunohistochemical
studies have localized neuropilin-2 to sympathetic nerve fibers in
synovial tissue from patients with RA and osteoarthritis (26), so
expression of semaphorin receptors by sympathetic neurons and
nerve fibers continues in adults. It is interesting that remodeling
of sympathetic innervation has been reported in the spleen of
rats with adjuvant-induced arthritis (28). In this model,
TH + nerve fiber abundance is reduced in the PALS and undergoes sprouting in the red pulp. Given the inflammatory milieu
present in the spleen during sepsis, it is feasible that increased
synthesis and release of semaphorins might occur and contribute
to sympathetic nerve loss (Figure 7).
Inflammatory cytokines might also contribute to sympathetic
nerve loss in the spleen. Excessive production of inflammatory
cytokines is a major cause of pathophysiology in patients with
sepsis, and some of these cytokines [i.e., interleukin-1β and
tissue necrosis factor-α (TNF-α)] have been implicated in CNS
neurodegeneration (46, 47). Sympathetic neurons are known to
contain receptors for several cytokines (48–52), and TNF-α in
particular has actions during development to promoted apoptosis
and inhibit neurite growth (49, 53). However, there is no evidence
for neurotoxic effects of cytokines on adult sympathetic neurons
and some can actually stimulate neurite growth (50–52). Thus,
it is unlikely that cytokines contribute to the TH + nerve loss in
patients with end stage sepsis.

Figure 5 | Quantification of tyrosine hydroxylase (TH) nerve fiber staining
shows a significant deficit in spleens from patients with end stage sepsis.
(A) Semi-quantitative evaluation of TH nerve fiber abundance was performed
using a grading scale ranging from 0 to 3 as described in Section “Materials
and Methods.” (B) Quantitative evaluation of TH nerve fiber abundance was
performed, as described in Section “Materials and Methods,” using ImageJ
to measure the % area occupied by TH + nerve fibers. Both methods
showed a significant reduction of TH + nerve fibers in spleen samples from
septic patients compared to control patients. Data in panel (A) were
evaluated using a two-tailed Mann–Whitney test for unpaired samples (n = 6
for control and n = 8 for septic; P = 0.0077). Data in panel (B) were
evaluated using a two-tailed t-test for unpaired samples (P = 0.0024). Values
are mean ± SD.

in RA (26). Semaphorin molecules are important axon guidance
factors during development and function by activating heteromeric receptors comprising a neuropilin ligand-binding unit
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Figure 6 | VAChT antibody labels cholinergic nerve fibers in human intestine. (A) Low magnification image showing the presence of VAChT + cholinergic nerve
fibers in a section of human intestine that was stained along with spleen sections. Asterisks indicate a ganglionated nerve plexus. Boxed region contains a ganglion
shown at high magnification in panel (B). Arrows indicates two of many VAChT nerve fibers that innervated intestinal smooth muscle (sm). (B) VAChT + nerve fibers
surrounding an enteric ganglion. (C) VAChT + nerve fibers in sm region shown at higher magnification. Scale bars: 100 µm (A); 50 µm (B,C).

these individuals are generally younger than sepsis patients.
Accordingly, we cannot eliminate the possibility that some loss
of sympathetic innervation occurred with aging. Age-related
loss of sympathetic nerves in spleen has been variable in animal
studies, depending on strain (15, 39). Patients with sepsis often
have multiple comorbidities, and we do not know if these affect
sympathetic innervation of the spleen. Therefore, it would be
important for future study to compare sympathetic innervation in of spleens from non-septic, elderly patients with and
without comorbidities. Despite these limitations, this study
has established a solid foundation that supports the translational potential for neuromodulation of immune function by
noradrenergic nerves in the spleen. Further work is needed to
define the phenotypes of splenocytes that receive noradrenergic
contacts, the abundance of such contacts, adrenergic receptors
expressed by different leukocyte populations, and plasticity of
both nerves and receptors in disease.
In summary, we present definitive evidence for the distribution of noradrenergic nerves in normal human spleen and the
first evidence for the presence of sympathetic nerves near leukocytes located in the PALS of human spleen. In addition, we
provide the first evidence for marked loss of noradrenergic nerves
in patients who died from sepsis. We speculate that loss of splenic
noradrenergic nerves may lead to impaired neuromodulation in
sepsis and this may not be limited to the spleen.

Figure 7 | Diagram illustrating potential mechanisms contributing to loss of
sympathetic nerves in end stage sepsis. Top panel shows normal condition
(control) where sympathetic innervation is maintained by nerve growth factor
(NGF), which is most likely supplied by T and B cells. The bottom panel
depicts changes in sepsis that could contribution to the loss of sympathetic
nerves. Loss of lymphocytes in the septic spleen would decrease the supply
of NGF, which is needed to maintain sympathetic nerves. Semaphorins,
which are nerve repellants, could be generated in the septic spleen and
cause retraction of sympathetic nerves through their interaction with the
neuropilin-2/plexin A2 receptor complex located on tyrosine hydroxylase
(TH) + nerve fibers. Toxic free radicals and inflammatory cytokines, generated
locally during sepsis, might contribute to degeneration of TH + nerve fibers.

While this study establishes that sympathetic innervation of
the spleen is reduced or lost in patients with end stage sepsis,
the clinical impact of this deficit remains a matter of speculation. One possibility is that sympathetic nerve loss might favor
immunosuppression, but it is also possible that altered immune
phenotype contributes to nerve loss. In any event, loss of sympathetic nerves would preclude any effects that they might have to
restore immune function in the spleen.
This study has some limitations that merit consideration.
Sample size was small but adequate for this initial inquiry.
More importantly, we had limited information on the clinical
history of sepsis patients. Knowing the duration of sepsis would
be useful since this parameter is likely to affect the magnitude
of nerve loss. In this regard, we did note that one patient had
sepsis for only a few days before dying, and that patient had
the highest nerve abundance within the sepsis group. Age
information was lacking for some of the trauma patients, but
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